North Macedonia vs Trinidad and Tobago: Previously treated cases tested for RR-/MDR-TB
North Macedonia
29.0%
in 2024
Trinidad and Tobago
27.0%
in 2024
North Macedonia rank
161st
Trinidad and Tobago rank
163rd
Previously treated cases tested for RR-/MDR-TB over time
- North Macedonia
- Trinidad and Tobago
How they compare
North Macedonia currently reports 29.0% against 27.0% in Trinidad and Tobago, a difference of 2.0%.
That makes North Macedonia's figure about 1.1 times Trinidad and Tobago's.
The two have swapped places 2 times across 18 shared years of data; in 2005 it was North Macedonia ahead.
North Macedonia ranks 161st and Trinidad and Tobago ranks 163rd of 180 countries.
North Macedonia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | North Macedonia | Trinidad and Tobago | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 33.2% | 23.3% | 9.9% | North Macedonia |
| 2010s | 77.4% | 44.8% | 32.6% | North Macedonia |
| 2020s | 77.4% | 32.0% | 45.4% | North Macedonia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, North Macedonia or Trinidad and Tobago?
- North Macedonia, at 29.0% against 27.0% in Trinidad and Tobago as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between North Macedonia and Trinidad and Tobago?
- 2.0%, with North Macedonia ahead.
- How many years of comparable data are there for North Macedonia and Trinidad and Tobago?
- 18 years are reported by both, from 2005 to 2024.
- How do North Macedonia and Trinidad and Tobago rank globally for previously treated cases tested for rr-/mdr-tb?
- North Macedonia ranks 161st and Trinidad and Tobago ranks 163rd of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.